Class II

/Tag: Class II

FDA: Stress Urinary Incontinence (SUI) Surgical Mesh Reports up 36 Percent

March 29, 2013 ~ In September 2011, the U.S. Food and Drug Administration convened a panel of experts to try and get a handle on the concerning number of complications the agency was receiving about surgical mesh used to treat pelvic organ prolapse (POP)  and stress urinary incontinence (SUI).  The experts  [...]

By |2018-07-10T13:10:44-04:00March 29th, 2013|FDA News|13 Comments

Coming Up: FDA Expert Panel Weighs in on Metal Hips

Next Wednesday, June 27 and Thursday, June 28, the U.S. Food and Drug Administration (FDA) will convene one of its expert panels - this one on patient complications after a metal-on-metal hip implant. It is a gathering called by the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory [...]

By |2012-06-20T00:12:08-04:00June 20th, 2012|FDA News|1 Comment

Consumer Reports: Dangerous Medical Devices

April 1, 2012 ~ The May issue of Consumer Reports (here)  features an investigation into synthetic mesh and artificial hips - medical devices that escape rigorous testing to assure safety. Tens of millions of Americans are living with medical devices and whether a defibrillator, artificial hip or surgical [...]

By |2012-04-02T14:27:15-04:00April 2nd, 2012|Media Reports|0 Comments

Upcoming Miami Hearing on Transvaginal Mesh Litigation and Consolidation

JANUARY 12, 2012 ~ A growing number of women from around the country who are plaintiffs in transvaginal mesh litigation have a court date of Wednesday, January 26 in Miami. The Judicial Panel on Multidistrict Litigation (MDL)  is set to hear requests by plaintiff attorneys to have thousands of defective [...]

By |2012-01-12T20:19:34-04:00January 12th, 2012|Legal News|2 Comments

FDA Panel Wants More Data on Mesh Tx for Incontinence, MedPage Today, September 9

MedPage Today (here)  reports an FDA advisory panel meeting over synthetic mesh used to treat stress urinary incontinence (SUI) said it would like more scientific data on the newer generation of devices but recommended leaving in place the 510(k) approval process. FDA Panel Listens to Industry, Patients, Staff The Obstetrics [...]

By |2011-09-13T01:50:01-04:00September 13th, 2011|Media Reports|0 Comments